Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 10 1997, 2602-2605, Vol 35, No. 10
E D'Agata, L Venkataraman, P DeGirolami and M Samore
We prospectively studied the acquisition of ceftazidime-resistant gram-
negative bacilli (CAZ-RGN) in two surgical intensive care units (SICU)
during a nonoutbreak period. Surveillance cultures were obtained from
patients at the time of admission and serially thereafter. CAZ-RGN isolates
were typed by pulsed-field gel electrophoresis (PFGE). Three hundred and
forty-three patients were enrolled from whom 1,621 baseline and follow-up
cultures were obtained. The most common species isolated from patients were
Pseudomonas aeruginosa (22), Enterobacter cloacae (21), Acinetobacter spp.
(13), Enterobacter aerogenes (11), Citrobacter spp. (10), Pseudomonas spp.
(non P. aeruginosa) (9), and Stenotrophomonas spp. (7). For each species,
PFGE strain types were highly diverse; no single type was recovered from
more than four patients. Twenty-eight patients acquired a CAZ-RGN during
the SICU stay; in six (21%), emergence of resistance from a previously
susceptible strain was documented on the basis of matching serial strain
types. Transmission of CAZ-RGN between patients occurred but was
infrequent, as judged by analyzing strain types of epidemiologically linked
patients. In conclusion, colonization with CAZ-RGN in SICU was associated
with diverse species and strains, as determined by molecular typing.
Emergence of resistance from previously susceptible strains appeared to be
more important than horizontal transmission in acquisition of CAZ-RGN in a
nonoutbreak period.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Molecular epidemiology of acquisition of ceftazidime-resistant gram- negative bacilli in a nonoutbreak setting
Division of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|